O
steoporosis is prevalent and treatable and conveys a considerable lifetime fracture risk, yet it remains substantially underdiagnosed and undertreated (1) (2) (3) (4) . Currently, nearly half of all female Medicare beneficiaries have never undergone bone mineral density (BMD) testing (5) , and more than 80% of all persons with a major osteoporosis-related fracture do not have BMD testing or receive pharmacologic agents to reduce fracture risk (6) . Furthermore, because normal BMD and mild osteopenia confer a very low risk for osteoporosis (7) , efficient and cost-effective stratification of the unscreened population into groups at low and high risk for osteoporosis and fractures is desirable. Central dual-energy x-ray absorptiometry (DXA) of the hips and lumbar spine is widely recognized as the reference standard for diagnosing osteoporosis (8, 9) , but it is underutilized. Safe and cost-effective alternatives to increase detection of this condition are needed.
More than 80 million computed tomography (CT) scans were performed in the United States in 2011 (10) , most of which carry potentially useful information about BMD. Retrieval of BMD data available on body CT examinations ordered for other indications requires no additional cost, patient time, equipment, software, or radiation exposure, and these data can be retrospectively acquired. It could therefore expand population screening efforts for osteoporosis.
In a recent feasibility study of adults who underwent osteoporosis screening with DXA and colorectal cancer screening with CT colonography, we showed that a single CT measurement of vertebral attenuation was equivalent to the more complex dedicated quantitative CT (QCT) assessment but was considerably easier to obtain (10) . The purpose of this study was to evaluate CT-derived BMD assessment compared with DXA screening by using CT scans that were performed for other clinical indications in a larger patient population, focusing on the L1 level because it is easily identified as the first non-rib-bearing vertebra and is included on all abdominal and thoracic CT scans in routine practice.
METHODS

Patient Cohort
The University of Wisconsin Health Sciences Institutional Review Board (Madison, Wisconsin) approved this Health Insurance Portability and Accountability Actadherent study. For inclusion, patients had to have had abdominal CT and central DXA scanning of the hips and spine within 6 months. All imaging was done at our insti-tution over 10 years ending in December 2009; image retrieval and study analyses were performed between 2010 and 2012.
Dual-Energy X-Ray Absorptiometry
Dual-energy x-ray absorptiometry of the lumbar spine and proximal femora was performed using standard techniques on Lunar Prodigy densitometers (GE Healthcare, Waukesha, Wisconsin). Patients were categorized as having osteoporosis (T-score Յ Ϫ2.5 or the presence of a moderate-to-severe vertebral compression fracture), osteopenia (T-score between Ϫ1.0 and Ϫ2.5), or normal BMD (T-score Ն Ϫ1.0) by using the lowest reported T-score (8, 11) . Because low BMD at 1 site carries an increased risk for fracture at other sites (12, 13) , patients are generally categorized and managed according to their lowest central T-score. Furthermore, in a substantial subset of cases, T-scores for 1 of the 2 central sites are not reported for various technical reasons. At least 1 valid reported T-score for the lumbar spine or hips was required for study inclusion.
Computed Tomography
Abdominal CT was done using multidetector CT scanners (LightSpeed Series, GE Healthcare) calibrated daily to ensure accurate vertebral CT-attenuation numbers, which reflect underlying BMD (Figure 1) . We retrospectively accessed the CT images and evaluated vertebral BMD on a standard radiology picture archiving and communication system workstation, with images viewed in soft tissue and bone windows (windows define gray-scale assignment of the image display to emphasize particular tissues and do not influence attenuation or BMD values [ Figure 1] ) (14) . We assessed vertebral BMD by placing a single oval click-and-drag region of interest (ROI) over an area of vertebral body trabecular bone and then measuring CT attenuation in Hounsfield units (HU), with lower HU (lower attenuation) representing less-dense bone, at each of the T12 through L5 levels ( Figures 1 and 2) ; this process is identical to that used for measuring CT attenuation for other clinical conditions (for example, adrenal adenomas, renal lesion enhancement, and fatty liver assessment). We avoided placing the ROI near areas that would distort the BMD measurement (posterior venous plexus; focal heterogeneity or lesion, including compression fracture; and imaging-related artifacts).
We assessed the presence of vertebral compression fractures by using sagittal CT views of the lumbar spine (Figure 2, B) by employing the Genant visual semiquantitative method (15) , a widely accepted way of assessing vertebral fractures on conventional radiography that can be easily applied to sagittal CT images. We counted only obvious moderate (grade 2, 25% to 40% loss of height) or severe (grade 3, Ͼ40% loss of height) compression deformities to avoid ambiguity related to more subjective borderline or mild compression deformities. All potential moderate-to-severe compression fractures identified on the initial review were verified in a separate reading session for final confirmation, further excluding any questionable mild fractures.
Statistical Analysis
We used Kruskal-Wallis tests to compare CTattenuation values within BMD categories at each vertebral level (T12 to L5). We constructed kernel-density plots of L1 CT attenuation for normal, osteopenic, and osteoporotic groups by using a Gaussian kernel with bandwidth selected according to the Silverman rule of thumb. We calculated sensitivity and specificity, positive and negative predictive values (PPVs and NPVs), and positive and negative likelihood ratios for CT imaging compared with DXA imaging across the range of observed CT-attenuation values at 5-HU increments to establish thresholds that would yield high sensitivity (about 90%), high specificity (about 90%), or a balance between the 2 for distinguishing osteoporosis from nonosteoporosis (osteopenia and normal BMD) and normal BMD from low BMD (osteoporosis and osteopenia).
We calculated adjusted Wald ("approximate") 95% CIs for proportions (for example, sensitivity and specificity) (16) and based the 95% CIs for PPV and NPV on the logarithmic method (17). We also report findings for more extreme thresholds (Ͻ100 HU and Ͼ200 HU) intended to further increase specificity for osteoporotic and normal populations, and we report CT-DXA cross-classifications at thresholds that divide the study sample approximately evenly among BMD categories.
Context
Osteoporosis is underdiagnosed.
Contribution
This study found that computed tomography (CT) scans can be used for detecting vertebral osteoporosis by comparing CT scans obtained for other reasons with dualenergy x-ray absorptiometry (DXA) scans performed within 6 months of the CT. Approximately half of patients with CT-identified osteoporotic vertebral compression fractures had nonsteoporotic T-scores (DXA false-negative results).
Caution
Osteoporosis treatment is often initiated based on hip fracture risk. The relationship between hip fracture risk and bone mineral density (BMD) is stronger for hip than for spine BMD measures.
Implication
CT scans obtained for other reasons can be used for opportunistic osteoporosis screening without additional radiation exposure or cost.
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Original Research We assessed CT performance across all thresholds for L1 and all vertebral levels by using empirical receiveroperating characteristic (ROC) curve analysis (18) . The ROC analyses derive from univariate logistic regression models, where DXA-based osteoporosis was the dependent variable and CT attenuation the independent variable. We also performed multivariable logistic regression by using all 6 single-level T12 to L5 attenuations as dependent variables; the linear predictor was then used to construct ROC curves. We assessed areas under the ROC curve (AUCs) and corresponding 95% confidence limits for each vertebral level and compared the values by using a nonparametric approach (19) .
In additional analyses, we compared CT performance with and without intravenous contrast administration (because venous enhancement could potentially elevate ROIattenuation values through volume-averaging effects).
Statistical calculations and graphics were performed using R, version 2.12.2 (R Development Core Team, Vienna, Austria) (20).
Role of the Funding Source
The National Institutes of Health funded this study. The funding source had no role in study design, conduct, or analysis or the decision to submit the manuscript for publication.
RESULTS
The study comprised 2063 CT-DXA pairs in 1867 adults (1511 women [81%]; mean age, 59.2 years [SD, 12.5]). The median time between abdominal CT and DXA studies was 67 days (interquartile range, 27 to 118 days).
Abdominal CT was done for various clinical indications, most commonly for suspected mass or oncologic work-up (n ϭ 414); genitourinary (n ϭ 402) or gastrointestinal (n ϭ 398) reasons, including virtual colonoscopy; and unexplained abdominal pain or symptoms (n ϭ 374) (Appendix Table 1 , available at www.annals.org). Of the 2063 CT scans, 1126 (54.6%) were obtained after intravenous contrast administration; the remainder were unenhanced. Fewer than 10% of patients contributed more than 1 CT-DXA pair because of imaging without and with contrast; analyses restricted to 1 CT-DXA pair per patient resulted in absolute changes to sensitivity or specificity less than 1% for all thresholds.
The DXA screening reference standard categorized patients as osteoporotic (22.9%), osteopenic (44.8%), and normal (32.3%); BMD categories at hip and vertebral levels differed in approximately half the study population (Appendix Tables 2 and 3 , available at www.annals.org). Computed tomography-attenuation values differed signif- Original Research CT Screening for Osteoporosis icantly for the 3 DXA-defined BMD categories at all vertebral levels (P Ͻ 0.001) (Appendix Figure 1 , available at www.annals.org). Figure 3 shows the overlap of DXAdefined BMD categories by L1 CT attenuation; Figure 4 is a scatterplot of L1 CT-attenuation values and DXA T-scores.
An L1 CT-attenuation threshold of 160 HU was 90% sensitive and a threshold of 110 HU was more than 90% specific for distinguishing osteoporosis from osteopenia and normal BMD; a threshold of 135 HU resulted in a balanced sensitivity and specificity of approximately 75% for each ( Table 1) . A CT-attenuation threshold intended to increase specificity for osteoporosis (Ͻ100 HU) yielded a PPV for osteoporosis of 68.4%; most (82%) "falsepositive" cases were classified as osteopenic by DXA. Appendix Table 4 (available at www.annals.org) shows CT-DXA cross-classifications at thresholds that divide the study sample approximately evenly among BMD categories.
The AUC across CT thresholds at L1 to distinguish osteoporosis from osteopenia or normal BMD ( Table 2 shows the diagnostic accuracy of CT for distinguishing normal from abnormal BMD (osteopenia and osteoporosis); an L1 CT-attenuation threshold of 135 HU was approximately 90% sensitive, and a threshold of 190 HU was 90% specific. A CT-attenuation threshold intended to increase specificity for normal BMD (Ͼ200 HU) yielded an NPV for osteoporosis of 99%; Appendix CT ϭ computed tomography; DXA ϭ dual-energy x-ray absorptiometry. A. Axial CT image at the L1 vertebral level viewed in a bone window setting shows appropriate placement of the oval region of interest in the trabecular bone. The CT-attenuation value of 109 HU places this patient in the lowest quintile, raising concern for osteoporosis. B. Sagittal CT view shows a moderate T12 compression fracture (arrow). Note that higher thoracic vertebral bodies are also sometimes included on abdominal CT scans. C and D. DXA evaluation of the hips (C) and lumbar spine (D) performed 3 mo later demonstrated osteopenic T-scores ranging from Ϫ1.1 to Ϫ1.9 (lowest T-score of Ϫ1.9 from L1 to L4 evaluation). Therefore, this represents a DXA false-negative result. Computed tomography performed similarly at other (non-L1) vertebral levels (Appendix Table 5 and Appendix Figure 3 , available at www.annals.org); attenuation thresholds targeted to yield sensitivity and specificity of approximately 90% varied slightly at each level because of the small average decrease in attenuation values toward the L3 level (Appendix Figure 1) . The AUCs were similar using single-level vertebral measurements, a single multilevel (T12 to L5) average, and more complex model-based multilevel measures (Appendix Figure 3) .
One hundred nineteen patients had at least 1 moderate or severe vertebral fracture (35 with fractures at multiple vertebral levels), 62 (52.1%) of whom had either osteopenic (n ϭ 50) or normal (n ϭ 12) DXA T-scores (Figures 2 and 4) . Presumed degenerative changes were noted in DXA evaluation in most of these false-negative cases, which may have resulted in spurious T-score results. Vertebral level L1 attenuation (or mean vertebral attenuation if L1 itself was involved by fracture) was 145 HU or less in 115 (96.6%) of these patients, compared with 39.0% of patients with a T-score greater than Ϫ2.5 and no fracture. Figure 4 shows the generalized decrease in vertebral CT attenuation among patients with fractures, despite a range of DXA T-scores encompassing normal values.
DISCUSSION
In this study of the diagnostic accuracy of a simple BMD screening method for adults who have undergone abdominal CT imaging for other clinical indications, we report results suggesting that CT images could be used to identify patients with osteoporosis or normal BMD. The method that we used requires a negligible amount of training and time; could be applied prospectively by the interpreting radiologist or retrospectively by a radiologist or even nonradiologist; adds no cost; and requires no additional patient time, equipment, software, or radiation exposure. It should not be confused with QCT, which is more labor-intensive; requires an imaging phantom or angle-corrected ROI measurement of bone, muscle, and fat at multiple levels (21); and involves additional money, time, and radiation exposure. Current QCT-derived T-scores do not directly correspond to DXA T-scores, limiting QCT clinical utility (21) . We previously showed that the simpler approach used in this study was as or more effective and more reproducible than spine QCT for predicting DXA results (14) .
Although optimal implementation of this method of CT screening for osteoporosis remains to be determined, our data suggest ways that it could be used in practice, depending on clinical objectives. Identifying persons with very low BMD by CT (for example, Ͻ100 HU at L1) The black circles represent patients with CT-detected T12 to L5 compression fractures (not shown here are 15 patients with L1 compression fractures where reliable CT-attenuation measurement at this level was not possible). Note the broad range of DXA T-scores among patients with vertebral fracture, including normal scores. Overall, more than half of all patients with fractures had a nonosteoporotic DXA T-score, but 97% had an L1 or mean vertebral attenuation Յ145 HU. CT ϭ computed tomography; DXA ϭ dual-energy x-ray absorptiometry.
Original Research CT Screening for Osteoporosis might allow for rapid identification of high-risk cohorts in whom further evaluation or treatment is warranted. Determining persons with high-normal BMD by CT (for example, Ͼ200 HU at L1) might effectively exclude osteoporosis and would probably make DXA unnecessary. For L1 trabecular CT-attenuation values between 100 and 200 HU, or for all patients across the range of attenuation values, various thresholds or ranges could be considered, perhaps on the basis of pretest probability or a priori risk. For example, an L1 CT-attenuation threshold of 160 HU (90% sensitive for distinguishing osteoporosis from nonosteoporosis) may be suitable for high-risk cohorts where the aim is to minimize false-negative results; a substantial subset of osteopenia cases would be included in this population, leading to low test specificity. Alternatively, an L1 threshold of 110 HU (91% specific) may be prudent for groups considered at lower risk to minimize false-positive results yet still detect approximately half (52%) of patients with osteoporosis. Other CTattenuation thresholds or vertebral levels can be used, depending on the population and screening objectives.
One clear advantage of CT over DXA BMD screening is its ability to accurately identify unsuspected osteoporotic compression fractures, which clearly diagnose osteoporosis independent of the patient's DXA T-score (1). Osteopenic and normal DXA T-scores were prevalent among patients with vertebral fractures in our study and in others (22, 23) ; this finding highlights the limitations of DXA, particularly in terms of BMD overestimation related to degenerative CT ϭ computed tomography; DXA ϭ dual-energy x-ray absorptiometry; FN ϭ false-negative; FP ϭ false-positive; NPV ϭ negative predictive value; PPV ϭ positive predictive value; TN ϭ true-negative; TP ϭ true-positive. * "Nonosteoporosis" is defined as having osteopenia or normal bone mineral density. In this table, osteopenia and normal bone mineral density (according to the DXA T-score) are considered negative findings. Patients with moderate or severe compression fractures were categorized as osteoporotic. The total number of CT scans is fewer than 2063 because L1 attenuation could not be reliably measured in 23 cases. Receiver-operating characteristic curves for the L1 vertebral level show no statistically significant difference in AUC for CT scans performed with and without intravenous contrast (P ϭ 0.91). However, further investigation is needed to determine whether any adjustment in specific CT-attenuation thresholds is necessary. AUC ϭ area under the receiveroperating characteristic curve; CT ϭ computed tomography. changes (1, 24) . Vertebral CT-attenuation values tended to be low at levels other than the site of fractures in our study, and the fractures themselves were readily visible on the sagittal views. Our observations are consistent with prior studies documenting that many patients without osteoporosis diagnosed by DXA will sustain fragility fractures (22, 23) and suggest that CT attenuation may be a more accurate risk indicator. Another possible advantage of CT over DXA screening is its scalability. We are currently assessing automation of CT BMD screening that would permit evaluation of numerous patients within the picture archiving and communication system file storage. Future refinements in appropriate population-specific CT-attenuation thresholds could be derived from large retrospective (or prospective) cohorts. In the future, it may even be possible to incorporate CT-attenuation data into fracture risk assessment tools, such as the FRAX tool (World Health Organization Collaborating Centre for Metabolic Bone Diseases, Sheffield, United Kingdom) (25) .
We emphasize L1 vertebral measures in this study for several reasons. First, the results at L1 are as or more accurate than the results at other levels, including multilevel assessment. The L1 level is easily identified, which improves efficiency and reproducibility. It is included on all standard chest and abdominal CT scans, substantially increasing its potential for higher overall screening yield. Accuracy was unaffected by the presence or absence of intravenous contrast. Furthermore, the measurement can be applied retrospectively, because CT scans are now typically stored indefinitely in most electronic medical records (picture archiving and communication systems).
Our study has limitations. Fracture risk prediction and osteoporosis treatment decisions are often determined by DXA-based hip T-scores. Our analysis is based on vertebral measures and excludes assessment of risk factors for clinical fracture important to the FRAX tool and other fracture risk calculators (26, 27) . Computed tomographic evaluation of the hip for BMD assessment is much more complex than the simple lumbar assessment that we propose, and we are currently investigating the potential for deriving a DXA-equivalent T-score for the hips from standard pelvic CT scans by using a dedicated software tool.
Our analysis is also based on DXA measures as a reference standard for assessing BMD, but the patients with vertebral fractures and osteopenia or normal BMD by DXA in our study highlight the limitations of use of DXA as a reference standard. This finding suggests that, in a clinical setting, cases with nonosteoporotic T-scores but very low CT-attenuation values may warrant further investigation for overlying degenerative changes. Finally, we did not formally assess the potential benefits and costs of using the CT thresholds that we identified, but we speculate that increasing detection of osteoporosis, with subsequent appropriate treatment to reduce fracture risk, combined with reducing the number of normal DXA studies, would be expected to yield substantial health care cost savings (28). CT ϭ computed tomography; DXA ϭ dual-energy x-ray absorptiometry; FN ϭ false-negative; FP ϭ false-positive; NPV ϭ negative predictive value; PPV ϭ positive predictive value; TN ϭ true-negative; TP ϭ true-positive. * "Nonosteoporosis" is defined as having osteopenia or normal bone mineral density. In this table, osteopenia (according to the DXA T-score) is combined with osteoporosis; normal bone mineral density is considered a positive result. Patients with moderate or severe compression fractures were categorized as having osteoporosis. The total number of CT scans is fewer than 2063 because L1 attenuation could not be reliably measured in 23 cases.
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In conclusion, we demonstrate how routine abdominal CT scans obtained for other clinical indications can be used for opportunistic osteoporosis screening without the need for additional imaging, radiation exposure, cost, equipment, or patient time. We also report accuracy statistics for various CT-attenuation thresholds, use of which would vary depending on clinical and population screening objectives. Refinement of our techniques and confirmation of these findings might justify more routine reporting of vertebral trabecular attenuation with readings of abdominal CT evaluations performed for any reason. The AUCs are similar at each individual vertebral level, using a multilevel T12 to L5 average, and in a multivariable model incorporating measures from all levels simultaneously, with broad overlap of 95% CIs. Osteopenia was considered a false-positive result for these calculations. The total number of assessable CT measurements per level was 2016 for T12, 2040 for L1, 2048 for L2, 2046 for L3, 2021 for L4, and 1943 for L5. AUC ϭ area under the receiver-operating characteristic curve; CT ϭ computed tomography.
